Hypertension — Blood Pressure Regulation - Role of Potassium
Citation(s)
15 Egfjord M, Dreier R, Ravn L, Hofman-Bang J. Extracellular potassium modulated aldosterone secretion in relation to hypertensive states. 2013. Submitted.
Adrogué HJ, Madias NE Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007 May 10;356(19):1966-78. Review.
Cargill RI, Coutie WJ, Lipworth BJ The effects of angiotensin II on circulating levels of natriuretic peptides. Br J Clin Pharmacol. 1994 Aug;38(2):139-42.
He J, Whelton PK Epidemiology and prevention of hypertension. Med Clin North Am. 1997 Sep;81(5):1077-97. Review.
Krishna GG, Miller E, Kapoor S Increased blood pressure during potassium depletion in normotensive men. N Engl J Med. 1989 May 4;320(18):1177-82.
Larsson SC, Orsini N, Wolk A Dietary potassium intake and risk of stroke: a dose-response meta-analysis of prospective studies. Stroke. 2011 Oct;42(10):2746-50. doi: 10.1161/STROKEAHA.111.622142.
Matthesen SK, Larsen T, Vase H, Lauridsen TG, Pedersen EB Effect of potassium supplementation on renal tubular function, ambulatory blood pressure and pulse wave velocity in healthy humans. Scand J Clin Lab Invest. 2012 Feb;72(1):78-86. doi: 10.3109/00365513.2011.635216.
Rainey WE, Bird IM, Mason JI The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol. 1994 Apr;100(1-2):45-50. Review.
Seidelin PH, McMurray JJ, Brown RA, Struthers AD The effect of angiotensin II and noradrenaline alone and in combination on renal sodium excretion in man. Br J Clin Pharmacol. 1989 Jun;27(6):803-9.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
